ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HCID 10607作成日:2026年11月1日

ポドフィロトキシン

ポドフィロックス · コンジロックス · (5R)-5,8,8aβ,9-テトラヒドロ-9β-ヒドロキシ-5-(3,4,5-トリメトキシフェニル)フロ[3',4':6,7]ナフト[2,3-d]-1,3-ジオキソール-6(5aαH)-オン · ポドフィリン酸ラクトン · (-)-ポドフィロトキシン · (5R)-5β-(3,4,5-トリメトキシフェニル)-9β-ヒドロキシ-5,5aα,6,8,8aβ,9-ヘキサヒドロフロ[3',4':6,7]ナフト[2,3-d]-1,3-ジオキソール-6-オン · (5R)-5β-(3,4,5-トリメトキシフェニル)-7α-(ヒドロキシメチル)-8β-ヒドロキシ-5,6,7,8-テトラヒドロナフト[2,3-d]-1,3-ジオキソール-6β-カルボン酸6,7-ラクトン · (5R)-5,5aα,8aβ,9-テトラヒドロ-9β-ヒドロキシ-5β-(3,4,5-トリメトキシフェニル)フロ[3',4':6,7]ナフト[2,3-d]-1,3-ジオキソール-6(8H)-オン

https://huagongshe.com/ja/chemical/10607

ポドフィロトキシン の分子構造式

識別子と物理属性

CAS No.477-47-4
分子式C22H22O8
平均分子量414.4 g/mol
単同位体質量414.13146766 g/mol
SMILESCOc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC
InChIKeyYJGVMLPVUAXIQN-XVVDYKMHSA-N
PubChem CID10607
ChEMBLCHEMBL61
ChEBICHEBI:50305
EC No.208-250-4
DTXSIDDTXSID3045645
現地名ポドフィロトキシン

化学・物理的性質

XLogP2
極性表面積92.7
水素結合供与体数1
水素結合受容体数8
回転可能結合数4
重原子数30
形式電荷0
複雑度629
LogP(分配係数)1.5log Kow = 2.01
Color/FormSolvated crystals
溶解度100Insoluble in ethyl ether, ligroinslightly soluble in watersoluble in acetone, benzenevery soluble in ethanol, chloroform.In water, 150 mg/L at 25 °C /Estimated/1.14e-01 g/LDMSO:15.0(Max Conc. mg/mL)36.2(Max Conc. mM)
融点228114-118 °C183 °CMP: 114-118 °C (effervescence)228 °C183-184 °C (lit.)
蒸気圧8.3X10-15 mm Hg at 25 °C /Estimated/
Optical RotationHygroscopic amorphos white flakes, mp = 152-154 °C. Specific optical rotation = -76.4 deg (c=0.576 in methanol)specific optical rotation = -117.0 deg (c=0.668 in pyridine) /Podophyllotoxin-beta-D-glucoside/Specific optical rotation = -132.7 deg @ 20 °C/D, chloroform, 2%
ヘンリー定数Henry's Law constant = 3.8X10-18 atm-cu m/mol at 25 °C /Estimated/
Physical DescriptionLight-brown to greenish-yellow powderCommercial resin preparations contain 5-25% podophyllum. [INCHEM]Solid
Collision Cross Section198.37 Ų [M+Na]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]189.74 Ų [M+H]+ [CCS Type: TW199.47 Ų [M+K]+ [CCS Type: TW187.85 Ų [M+H-H2O]+ [CCS Type: TW190.1 Ų [M+H-H2O]+ [CCS Type: TW189.6 Ų [M+H]+ [CCS Type: TW
Other Experimental PropertiesSeveral polymorphic modifications. After drying up: mp = 183.3-184.0 °C. Specific optical rotation = -132.7 deg @ 20 °C/D (chloroform). Solubility in water at 23 °C = 12- mg/L. Soluble in alcohol, chloroform, acetone, warm benzene, glacial acetic acid.MW: 414.40. Crystals from acetone. MP = 214 °C. Higher-melting modification from abs ethanol, mp 228 °C. Specific optical rotation = +9.4 deg (c=0.7 in chloroform). Solubility in water at 25 °C approx 100 mg/L. Fairly soluble in chloroform, hot ethanol, acetic acid, acetone, dilute causticless soluble in benzene ether, carbon tetrachloride, propylene glycol. /Picropodophyllin/Hydroxyl radical reaction rate constant = 2.2X10-10 cu cm/molecule-sec at 25 °C /Estimated/
比旋光度-110.7 º (c=1, CHCl3)
沸点453.31°C (rough estimate)
密度1.2649 (rough estimate)
屈折率1.4480 (estimate)
貯蔵条件2-8°C
pKa(酸解離定数)13.26±0.40(Predicted)
外観・状態粉
色ホワイトからオフホワイト
Merck13,7628
BRN99163
安定性非常に吸湿性
InChIKeyYJGVMLPVUAXIQN-XVVDYKMHSA-N
SMILESCOc1cc(cc(OC)c1OC)[C@H]2C3C(COC3=O)[C@@H](O)c4cc5OCOc5cc24
LogP(分配係数)2.010
CAS データベース518-28-5(CAS DataBase Reference)

化学的特性

off-white fine crystalline powder

安全性と法規制

GHS 分類This chemical does not meet GHS hazard criteria for 2.2% (1 of 46) of reports.DangerH301 (93.5%): Toxic if swallowed [Danger Acute toxicity, oral]H310 (95.7%): Fatal in contact with skin [Danger Acute toxicity, dermal]H315 (97.8%): Causes skin irritation [Warning Skin corrosion/irritation]H319 (97.8%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]H335 (95.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposureRespiratory tract irritation]P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 46 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.Reported as not meeting GHS hazard criteria per 1 of 46 reports by companies.There are 7 notifications provided by 45 of 46 reports by companies with hazard statement code(s).Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
規制情報Chemical: Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, [5R-(5.alpha.,5a.beta.,8a.alpha.,9.alpha.)]-
その他の安全情報IMAP assessments - Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, [5R-(5.alpha.,5a.beta.,8a.alpha.,9.alpha.)]-: Environment tier I assessmentIMAP assessments - Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, [5R-(5.alpha.,5a.beta.,8a.alpha.,9.alpha.)]-: Human health tier I assessment
火災の可能性Podofilox topical gel is flammable and should be kept away from open flames.
有害性の概要The main active constituent of the resin from the roots of may apple or mandrake (Podophyllum peltatum and P. emodi). It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives. [ChemIDplus]

用途

解説

C22H22O8(414.40).ポドフィロトキシンは,メギ科Podophyllum peltatumなどの地下茎からβ-D-グルコシドとして得られる.融点114~118 ℃.[α]20D-132°(クロロホルム).エタノールや有機溶媒に可溶,水に難溶.抗腫瘍作用を有するが,毒性が強く,皮膚に炎症を起こす.LD50 8.7 mg/kg(ラット,静注).森北出版「化学辞典(第2版)

用途

ポドフィロトキシン(podophyllotoxin, PPT、ポドフィロックス)は、ポドフィルム属植物の根および根茎に含まれる毒性リグナンである。局所ゲル剤がコンジロックスの商品名で、一部のヒトパピローマウイルスが原因の外性器尖圭コンジローマの治療に用いられる。ポドフィロトキシンおよびその誘導体(エトポシド、テニポシド、エトポホス)は、瀉下薬、発疱薬、抗リウマチ薬、抗ウイルス薬、抗腫瘍剤と幅広く応用されている。これらの抗がん活性は精力的に研究されており、肺がん、リンパ腫、生殖器腫瘍などに対する治療に使用されている。

説明

Podophyllotoxin (2,3-butyl-4-aromatic naphthene) is isolated from guijiu(Podophyllum) . There are two species as the main source of podophyllotoxin, Podophyllum hexandrum Royle and Podophyllum peltatum .Although podophyllotoxin has significant antitumor and antiviral activities, it showed several toxicity and side effects. Podophyllotoxin derivatives, etoposide (VP-16-213), Etopophos, amino sugar etoposide (NK6l1), and teniposide (VM26), have been developed as anticancer drugs. They are used to treat small cell lung cancer, testicular cancer, acute leukemia, malignant lymphoma, etc. But podophyllotoxin derivatives are not free of toxicity. Besides the narrowing of the anticancer spectrum and low water solubility, these drugs could induce severe myelosuppression, gastrointestinal side effects, etc.Although the synthetic and biosynthetic pathways of podophyllotoxin have been elucidated, it is still the most effective, economic, and fast way to extract podophyllotoxin from the plant.

来歴

Podophyllotoxin was first found in the Podophyllum peltatum L.The first time to isolate podophyllotoxin from podophyllin was in 1880. In 1942, it was found that venereal warts could be effectively treated by application of podophyllin.Subsequently, podophyllotoxin was reported to inhibit the growth of the tumor through the inhibition of the microtubule formation. The chemical structure of podophyllotoxin was elucidated in 1951.In the 1960s, two main podophyllotoxin derivatives were synthesized, etoposide and teniposide (VM-26) . In 1983, etoposide was approved by FDA.Etoposide and teniposide are used in frontline cancer therapy against various cancer types, such as small cell lung cancer, testicular cancer, etc. In 1996, etoposide phosphate analog (Etopophos) was launched in America. Etopophos is the prodrug of etoposide and can be rapidly absorbed and completely converted to the parent compound invivo. In 1990, WHO recommended 0.5% podophyllotoxin as the first-line drug for the treatment of condyloma acuminatum. Podophyllotoxin creams and gels are nowadays widely used in clinical practice.

使用

Podophyllotoxin is a non-alkaloid toxin lignan extracted from the roots and rhizomes of Podophyllum species. It binds to topoisomerase II during the late S and early G2 stage, blocking tubulin polymerization and, thus, inhibiting mitosis. In addition to being used as a cathartic, purgative, antiviral agent, vesicant, and antihelminthic, podophyllotoxin is the starting material for the semi-synthesis of the anti-cancer drugs etoposide , teniposide , and etopophos.

製法・合成法

純化方法

The toxin recrystallises form *C6H6 (with 0.5C6H6), EtOH/*C6H6, aqueous EtOH (with 1-1.5H2O, m 114-115o) and CH2Cl2/pentane. When dried at 100o/10mm it has m 183-184o. [UV: Stoll et al. Helv Chim Acta 37 1747 1954, IR: Schecler et al. J Org Chem 21 288 1956.] It is an inhibitor of microtubule assembly [Prasad et al. Biochemistry 25 739 1986]. [Beilstein 19/10 V 666.]

FDA 要件The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl podofilox, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.
Hazard Classes and CategoriesAcute Tox. 3 (93.5%)Acute Tox. 2 (95.7%)Skin Irrit. 2 (97.8%)Eye Irrit. 2 (97.8%)STOT SE 3 (95.7%)
保管条件Podofilox topical gel and topical solution should be stored at 15-30 °C. These preparations should not be exposed to excessive heatfreezing should be avoided. ...
処分方法SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air qualitypotential migration in soil or watereffects on animal, aquatic, and plant lifeand conformance with environmental and public health regulations.
暴露経路Topical application of 0.05 mL of 0.5% podofilox solution to external genitalia did not result in detectable serum levels. Applications of 0.1 to 1.5 mL resulted in peak serum levels of 1 to 17 ng/mL one to two hours after application.
毒性の概要IDENTIFICATION: Podophyllum is a dermatological medication. Origin of the substance: Dried resin from the roots and rhizomes of Podophyllum peltatum (Mandrake or May apple plant) the North American varietyactive ingredients are lignans including podophyllotoxins (20%), alpha-peltatin (10%) and beta-peltatin (5%). It is a light brown to greenish yellow solid powder soluble in water, alcohol, chloroform, acetone, warm benzene and glacial acetic acid. Indications: Wart or corn removal preparation. Description: Podophyllum resin has an antimitotic action and is used principally as a topical treatment for ano-genital warts (condylomata acuminata). Podophyllum resin has been used on external genital, perianal and intrameatal warts, but should not be used on cervical or urethral warts. Care must be taken to avoid application to healthy tissue. Podophyllum resin is also used in an ointment for plantar warts. Podophyllum resin has been used as a laxative, but when taken by mouth, it has a marked purging action and it is highly irritating to the intestinal mucosa and produces violent peristalsis. It has been superseded by less toxic laxatives. HUMAN EXPOSURE: Main risk and target organs: Podophyllum resin's major active constituent, podophyllotoxin, is a lipid soluble compound that readily crosses cell membranes. Podophyllotoxin and its derivatives are potent cytotoxic agents that inhibit cell mitosis and deoxyribonucleic acid (DNA) synthesis in a manner similar to that of colchicine. Cell division is arrested and other cellular processes are impaired, gradually resulting in the disruption of cells and destruction of the tissue. Topical podophyllum is easily absorbed systemically and can cross the placenta. Either local application or oral ingestion may produce multisystem toxic effects. Summary of clinical effects: Features of systemic toxicity include nausea and vomiting (which may be persistent), tachypnea, fever, stupor, coma, tachycardia, hypotension, paralyticEtoposide, a semisynthetic derivative of podofilox, induces DNA breakage through its inhibition of topoisomerase II. The drug is most active in the late S and early G2 phases of the cell cycle. Teniposide is an analog with very similar pharmacologic characteristics. Podofilox derivatives display binding activity to the enzyme topoisomerase II during the late S and early G2 stage. For instance, etoposide binds and stabilizes the temporary break caused by the enzyme, disrupts the reparation of the break through which the double-stranded DNA passes, and consequently stops DNA unwinding and replication. Mutants resistant to either podofilox, or to its topoisomerase II inhibitory derivatives such as etoposide (VP-16), have been described in Chinese hamster cells. The mutually exclusive cross-resistance patterns of these mutants provide a highly specific mean to distinguish the two kinds of podofilox derivatives. Mutant Chinese hamster cells resistant to podofilox are affected in a protein P1 that was later identified as the mammalian HSP60 or chaperonin protein. (Wikipedia)
Natural Pollution SourcesFound in the rhizomes of North American Podophyllum peltatum L., Podophyllaceae ... also in P. emodi ... in Juniperus virginiana L., Cupressaceae.
Human Toxicity Excerpts/HUMAN EXPOSURE STUDIES/ Toxicity reported following systemic administration of podofilox in investigational use for cancer treatment included: nausea, vomiting, fever, diarrhea, bone marrow depression, and oral ulcers. Following 5 to 10 daily intravenous doses of 0.5 to 1 mg/kg/day, significant hematologic toxicity occured but was reversible. Other toxicities occurred at lower doses. Toxicity reported following systemic administration of podophyllum resin included : nausea, vomiting, diarrhea, peripheral neuropathy, altered mental status, lethargy, coma , tachypnea, respiratory failure, leukocytosis, pancytosis, hematuria, renal failure, and seizures.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Non-Human Toxicity Excerpts/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ There are published reports that, in mouse studies, crude podophyllin resin (containing podofilox) applied topically to the cervix produced changes resembling carcinoma in situ. These changes were revisable at five weeks after cessation of treatment. In one reported experiment, epidermal carcinoma of the vagina and cervix was found in 1 out of 18 mice after 120 applications of podophyllin (the drug was applied twice weekly over a 15-month period). /Podophyllin resin//LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ Podofilox was embryotoxic in rats that were given daily intraperitoneal doses of 5 mg/kg of body weight (29.5 mg per square meter of body surface areacorresponding to 19 times the maximum human recommended dose). It was not teratogenic in rats that were given daily topical doses of 0.21 mg/kg of body weight (2.95 mg per square meter of body surface areacorresponding to two times the maximum human recommended dose for 13 days./LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ Podofilox did not impair fertility in two generations of rats given daily topical doses of 0.2 mg/kg of body weight (1.18 mg per square meter of body surface area) (corresponding to the recommended human daily dose) during gametogenesis, mating, gestation, parturition, and lactation./GENOTOXICITY/ Podofilox is not mutagenic according to the Ames plate reverse mutation assay (at concentrations up to 5 mg podofilox, with or without metabolic activation) and BALB/3T3 cells (at concentrations up to 0.008 ug/mL without metabolic activation and 12 ug/mL with activation). Chromosome damage occurs at higher doses25 mg/kg (75 mg per square meter of body surface area) of podofilox caused disruption and breakage of chromosomes in vivo in the mouse micronucleus assay.
Antidote and Emergency TreatmentTreatment of systemic toxicity or accidental ingestion is essentially supportive. To decrease absorption: Wash the skin free of any remaining drug. Supportive care: Patients in whom intentional overdose is known or suspected should be referred for psychiatric consultation.
Non-Human Toxicity ValuesLD50 Rat iv 8.7 mg/kgLD50 Rat ip 15 mg/kg
F1-8-10
水環境危害等級(WGK)3
RTECS 番号LV2500000
輸送番号(UN)UN 3462 6.1/PG 2
毒性LD50 in rats (mg/kg): 8.7 i.v.15 i.p. (Phillips)
税関コード29189090
危険文句(R)21-25-36/37/38-23/25-23/24/25
危険表示T
安全措置(S)36/37/39-45-26
危険等級6.1(a)Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
包装等級II
貯蔵分類6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials
有害物質データ518-28-5(Hazardous Substances Data)